Spyridon Siafis

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 17

Top Venues

BMJ open

Psychological medicine

Brain sciences

British journal of clinical pharmacology

Aristotle University of Thessaloniki School of Medicine (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Aristotle University of Thessaloniki School of Medicine

Greece

PHD

Publications

Spyridon Siafis, Johannes Schneider-Thoma, Tasnim Hamza, Irene Bighelli, Shimeng Dong, Wulf-Peter Hansen, John M Davis, Georgia Salanti, Stefan Leucht
Efficacy of clozapine compared with other second-generation antipsychotic drugs in patients with treatment-resistant schizophrenia: protocol for a systematic review and individual patient data meta-analysis of randomised controlled trials. BMJ open 13 (2) (2023)
Andrea Cipriani, Soraya Seedat, Lea Milligan, Georgia Salanti, Malcolm Macleod, Janna Hastings, James Thomas, Susan Michie, Toshiaki A Furawaka, David Gilbert, Karla Soares-Weiser, Carmen Moreno, Stefan Leucht, Matthias Egger, Parisa Mansoori, James M Barker, Spyridon Siafis, Edoardo Giuseppe Ostinelli, Robert McCutcheon, Simonne Wright, Matilda Simpson, Olufisayo Elugbadebo, Virginia Chiocchia, Thomy Tonia, Rania Elgarf, Ayse Kurtulmus, Emily Sena, Ouma Simple, Niall Boyce, Sophie Chung, Anjuli Sharma, Miranda Wolpert, Jennifer Potts, Julian H Elliott
New living evidence resource of human and non-human studies for early intervention and research prioritisation in anxiety, depression and psychosis. BMJ mental health 26 (1) (2023)
Spyridon Siafis, Johannes Schneider-Thoma, Tasnim Hamza, Irene Bighelli, Shimeng Dong, Wulf-Peter Hansen, John M Davis, Georgia Salanti, Stefan Leucht
Efficacy of clozapine compared with other second-generation antipsychotic drugs in patients with treatment-resistant schizophrenia: protocol for a systematic review and individual patient data meta-analysis of randomised controlled trials. BMJ open 13 (2) (2023)
Spyridon Siafis, Johannes Schneider-Thoma, Tasnim Hamza, Irene Bighelli, Shimeng Dong, Wulf-Peter Hansen, John M Davis, Georgia Salanti, Stefan Leucht
Efficacy of clozapine compared with other second-generation antipsychotic drugs in patients with treatment-resistant schizophrenia: protocol for a systematic review and individual patient data meta-analysis of randomised controlled trials. BMJ open 13 (2) (2023)
Spyridon Siafis, Hui Wu, Dongfang Wang, Angelika Burschinski, Nobuyuki Nomura, Hiroyoshi Takeuchi, Johannes Schneider-Thoma, John M Davis, Stefan Leucht
Antipsychotic dose, dopamine D2 receptor occupancy and extrapyramidal side-effects: a systematic review and dose-response meta-analysis. Molecular psychiatry (2023)
Spyridon Siafis, Nicola Bursch, Katharina Müller, Lisa Schmid, Florian Schuster, Jakob Waibel, Tri Huynh, Florian Matthes, Alessandro Rodolico, Peter Brieger, Markus Bühner, Stephan Heres, Stefan Leucht, Johannes Hamann
Evidence-based Shared-Decision-Making Assistant (SDM-assistant) for choosing antipsychotics: protocol of a cluster-randomized trial in hospitalized patients with schizophrenia. BMC psychiatry 22 (1) (2022)
Spyridon Siafis, Oğulcan Çıray, Hui Wu, Johannes Schneider-Thoma, Irene Bighelli, Marc Krause, Alessandro Rodolico, Anna Ceraso, Giacomo Deste, Maximilian Huhn, David Fraguas, Antonia San José Cáceres, Dimitris Mavridis, Tony Charman, Declan G Murphy, Mara Parellada, Celso Arango, Stefan Leucht
Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis. Molecular autism 13 (1) (2022)
Alessandro Rodolico, Concerto Carmen, Alessia Ciancio, Spyridon Siafis, Laura Fusar-Poli, Carla Benedicta Romano, Elisa Vita Scavo, Antonino Petralia, Salvatore Salomone, Maria Salvina Signorelli, Stefan Leucht, Eugenio Aguglia
Validation of the Glasgow Antipsychotic Side-Effect Scale (GASS) in an Italian Sample of Patients with Stable Schizophrenia and Bipolar Spectrum Disorders. Brain sciences 12 (7) (2022)
Stefan Leucht, Spyridon Siafis, Rolf R Engel, Johannes Schneider-Thoma, Irene Bighelli, Andrea Cipriani, Toshi A Furukawa, John M Davis
How Efficacious Are Antipsychotic Drugs for Schizophrenia? An Interpretation Based on 13 Effect Size Indices. Schizophrenia bulletin (2021)
Spyridon Siafis, Alessandro Rodolico, Oğulcan Çıray, Declan G M Murphy, Mara Parellada, Celso Arango, Stefan Leucht
Imputing the Number of Responders from the Mean and Standard Deviation of CGI-Improvement in Clinical Trials Investigating Medications for Autism Spectrum Disorder. Brain sciences 11 (7) (2021)
Vasileios-Periklis Stamatellos, Spyridon Siafis, Georgios Papazisis
Disease-modifying agents for multiple sclerosis and the risk for reporting cancer: A disproportionality analysis using the US Food and Drug Administration Adverse Event Reporting System database. British journal of clinical pharmacology (2021)
Spyridon Siafis, John M Davis, Stefan Leucht
Antipsychotic drugs: from 'major tranquilizers' to Neuroscience-based-Nomenclature. Psychological medicine 51 (3) (2020)
Dimitrios Spachos, Spyridon Siafis, Panagiotis D Bamidis, Dimitrios Kouvelas, Georgios Papazisis
Combining big data search analytics and the FDA Adverse Event Reporting System database to detect a potential safety signal of mirtazapine abuse. Health informatics journal 26 (3) (2020)
Spyridon Siafis, Oğulcan Çıray, Johannes Schneider-Thoma, Irene Bighelli, Marc Krause, Alessandro Rodolico, Anna Ceraso, Giacomo Deste, Maximilian Huhn, David Fraguas, Dimitris Mavridis, Tony Charman, Declan G M Murphy, Mara Parellada, Celso Arango, Stefan Leucht
Placebo response in pharmacological and dietary supplement trials of autism spectrum disorder (ASD): systematic review and meta-regression analysis. Molecular autism 11 (1) (2020)
Johannes Hamann, Miriam John, Fabian Holzhüter, Spyridon Siafis, Peter Brieger, Stephan Heres
Shared decision making, aggression, and coercion in inpatients with schizophrenia. European psychiatry : the journal of the Association of European Psychiatrists 63 (1) (2020)
Spyridon Siafis, Giacomo Deste, Anna Ceraso, Christian Mussoni, Antonio Vita, Senad Hasanagic, Johannes Schneider-Thoma, Georgios Papazisis, John M Davis, Stefan Leucht
Antipsychotic drugs v. barbiturates or benzodiazepines used as active placebos for schizophrenia: a systematic review and meta-analysis. Psychological medicine 50 (15) (2019)
Spyridon Siafis, Georgios Papazisis
Detecting a potential safety signal of antidepressants and type 2 diabetes: a pharmacovigilance-pharmacodynamic study. British journal of clinical pharmacology 84 (10) (2018)

Spyridon Siafis.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Spyridon Siafis